Natalia Baran: New Perspectives on Relapsed/Refractory AML at Leuko2026
Natalia Baran/ LinkedIn

Natalia Baran: New Perspectives on Relapsed/Refractory AML at Leuko2026

Natalia Baran, Adjunct Associate Professor at The University of South Dakota, Sanford School of Medicine, shared an update from OncoDaily, on LinkedIn, adding:

“So excited to join my esteemed colleagues Prof. Wierzbowska and Prof. Marta Sobas for this vital conversation on emerging strategies in relapsed/refractory AML. Looking forward to an inspiring exchange of insights at Leuko2026!

Quoting OncoDaily:

“Don’t miss this AML discussion at Leuko 2026!

Natalia Baran

Join Prof. Natalia Baran, Prof. Agnieszka Wierzbowska, and Prof. Marta Sobas for an expert panel discussion exploring new treatment approaches, evolving strategies, and the future of AML care.

The conversation you won’t want to miss!

September 3–4, 2026
Leuko 2026 Global Virtual Congress

Register now: LeukO 2026: Global Virtual Congress on Leukemias

Natalia Baran: New Perspectives on Relapsed/Refractory AML at Leuko2026

Other articles featuring Natalia Baran on OncoDaily.